Is Concentrix Corp. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison to peers, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, reinforcing Concentrix's relative attractiveness.
Despite this favorable valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -8.48% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 65.62%, suggests that while the company is currently undervalued, market sentiment may still be weighing heavily on its stock price.